Revolutionizing Painless Drug Delivery
Drugs, vaccines, and supplements temperature-stable, easy to use, and accessible worldwide.
Patch Technology
Compound delivery with an unprecedented combination of diverse applications, cost savings, ease of use, and improved patient access.
How Our Technology Works
Precise Microneedles
Our ultra-fine microneedles are barely perceptible within the skin, delivering target compounds painlessly and effectively.
Time-Release Formula
A single application can deliver multiple doses over time, eliminating the need for additional visits or injections.
Thermal Stability
Our patches remain stable at room, body, and shipping temperatures.
Versatile Applications
Adaptable delivery system suitable for a wide range of therapeutic and preventative use cases.
Expert Insight: STM's patented platform and unique formulations are the only patches capable of economically and technologically meeting the diverse needs within the animal and human drug, vaccine, and supplement markets.
Transformative Benefits
Our microneedle patch technology addresses key challenges in vaccine delivery, offering significant advantages over traditional methods.
No Boosters Needed
Single application delivers multiple doses over time, eliminating the need for boosters.
No Refrigeration
Temperature-stable formulation removes cold chain requirements for transportation and storage.
Painless Application
Microneedles are virtually imperceptible, creating a pain-free experience for patients.
Improved Outcomes
Controlled release pattern optimizes immune response for better overall protection.
Reduced Personnel
Simple application process doesn't require trained medical staff, expanding access globally.
No Biohazard Waste
Dissolving microneedles eliminate sharps waste disposal issues associated with traditional needles.
Versatile Applications
Our technology extends beyond human vaccines, opening limitless possibilities to improve community health across multiple fields.
Our microneedle patches are designed to deliver a wide range of applications with greater comfort and convenience.
- Repeat doses of therapeutics to increase access and patient compliance
- Ideal for mass/endemic vaccination campaigns
- Potential for self-administration
- Reduce patient anxiety and hesitancy
Revolutionizing animal health and veterinary care with easy-to-apply patches that reduce stress for both animals and handlers.
- Safer for animals and staff
- No missed doses or broken needles
- Lowered labor/shipping/storage costs
- Faster field/office application
Exploring applications beyond pharma, including efficient delivery of vitamins and supplements through the skin.
- Controlled release of nutrients
- Improved bioavailability
- Bypass digestive system
- Potential for personalized formulations
Human Pharma
Human Pharma
Our microneedle patches are designed to deliver a wide range of applications with greater comfort and convenience.
- Repeat doses of therapeutics to increase access and patient compliance
- Ideal for mass/endemic vaccination campaigns
- Potential for self-administration
- Reduce patient anxiety and hesitancy
Animal Health
Animal Health
Revolutionizing animal health and veterinary care with easy-to-apply patches that reduce stress for both animals and handlers.
- Safer for animals and staff
- No missed doses or broken needles
- Lowered labor/shipping/storage costs
- Faster field/office application
Nutraceuticals
Nutraceuticals
Exploring applications beyond pharma, including efficient delivery of vitamins and supplements through the skin.
- Controlled release of nutrients
- Improved bioavailability
- Bypass digestive system
- Potential for personalized formulations
Research & Publications
Our technology is backed by extensive peer-reviewed research and clinical studies validating its efficacy and safety.
Single-Administration Self-Boosting Microneedle Patch for The Treatment of Obesity
A Single-Administration Microneedle Skin Patch for Multi-Burst Release of Vaccine against SARS-CoV-2
Transdermal microneedles for the programmable burst release of multiple vaccine payloads
Our Expert Team
Led by industry pioneers and supported by world-class advisors, our team combines expertise in immunology, engineering, and global health.
Jasdeep Singh, Ed.D., MBA
Co-Founder & CEO
Seasoned science and organizational leader in both private and public sectors, market leader, 2x startup founder, dedicated community health and One Health advocate.
Thanh Duc Nguyen, Ph.D.
Co-Founder & CTO
Associate professor of mechanical engineering at the University of Connecticut, innovator, 2x startup founder 9x patent holder, and research leader who has raised over $5M in grant and private funding.
Nicholas Farrell, M.S.
Engineer and Researcher
Biomedical engineer specializing in materials, automation, and engineering. Innovator, graduate from Nguyen lab.
Morgan Hunte
Biological Research
Pathobiology doctoral candidate, infectious disease and vaccine development research at Sanofi, animal and human health expertise.
Steve Szczepanek
Clinical Application Lead
Associate professor of immunology and virology at the University of Connecticut, recognized international human and animal health leader, pathobiology innovator, and market application expert.
Join Our Team
We're always looking for talented scientists, engineers, and business professionals who are passionate about transforming global health with innovative technology.
Press & Recognition
Our innovative approach to vaccine delivery has been recognized by leading media outlets and industry experts.
Audience Winner of 2025 Kiasco London
STM was voted by the industry experts and leaders in attendance at Kisaco's Animal Health and Nutrition and Technology Innovation conference in London, its premier event, as best pitch. This award was validation of STM's ability to meet multiple market needs at a very large scale but cost efficient way.
Read the full announcementWinner of 2024 SXSW Pitch Competition
STM was recognized at South by Southwest 2024 for our revolutionary approach to vaccine delivery. Our single-time microneedle technology impressed judges with its potential to solve critical challenges in global immunization programs, particularly in regions with limited healthcare infrastructure.
Read the full announcementSTM Triumphs at SXSW 2024: Revolutionary Microneedle Platform Wins Prestigious Pitch Competition
STM emerged victorious in the highly competitive Food, Nutrition, and Health category at SXSW 2024, with CEO Jasdeep Singh showcasing their game-changing microneedle drug delivery platform. Unlike AI-dominated competitors, STM's innovative technology creates temperature-stable patches that eliminate costly cold-chain storage requirements and enable immediate, sustained, or multi-dose therapeutic delivery in a single application.
STM Partners with UConn to Pioneer Thermally-Stable Microneedle Vaccine Technology
STM, collaborating with UConn researchers, has developed groundbreaking microneedle patch technology using advanced sugar molecule stabilization to eliminate cold-chain storage requirements. The self-administered patch maintains vaccine stability at extreme temperatures and demonstrates successful antibody responses in preclinical COVID-19 studies, promising to transform global vaccine distribution by removing barriers like refrigeration infrastructure and making life-saving vaccines accessible in underserved communities worldwide.
STM Selected for Prestigious gBETA Medtech Accelerator Among Elite Healthcare Innovators
STM was chosen as one of only five startups for the highly competitive gBETA Medtech virtual accelerator spring 2022 cohort, standing out among hundreds of applicants for their groundbreaking needle-free vaccine delivery solution. Led by visionary CEO Jasdeep Singh and co-founded with renowned University of Connecticut Assistant Professor Thanh Nguyen, STM distinguished itself with their revolutionary removable transdermal microneedle patch.
STM Showcases Breakthrough Technology at World Vaccine Congress as Featured Startup
STM was prominently featured among select innovative startups at the World Vaccine Congress, demonstrating their industry-leading microneedle vaccine delivery platform to global healthcare leaders and investors. CEO Jasdeep Singh and co-founder Professor Thanh Nguyen presented their game-changing technology that delivers single or multiple vaccine doses through one simple patch application, positioning STM as a transformative force in global health.
Get In Touch
Interested in learning more about our technology or exploring partnership opportunities? Reach out to our team.